Form 4 Sight Sciences, Inc. For: Jan 17 Filed by: Badawi David
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Sight Sciences, Inc. For: Jan 16 Filed by: Badawi Paul
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Sight Sciences, Inc. For: Jan 17 Filed by: HAYDEN JEREMY B.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form S-1MEF Hepion Pharmaceuticals,
As filed with the U.S. Securities and Exchange Commission on January 21, 2025.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Hepion Pharmaceuticals, Inc.
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant’s Name into English)
Delaware 2834 ... (continue reading...)
Form 4 BEYOND, INC. For: Jan 21 Filed by: TABACCO JOSEPH J JR
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 BEYOND, INC. For: Jan 21 Filed by: Shapiro Robert Jacob
-
Form 4 BEYOND, INC. For: Jan 21 Filed by: Corbus Barclay F
-
Form 4 BEYOND, INC. For: Jan 21 Filed by: Nettles William Benjamin JR
-
Form 4 Natera, Inc. For: Jan 16 Filed by: Sheena Jonathan
-
Form 4 Natera, Inc. For: Jan 16 Filed by: RABINOWITZ DANIEL
-
Form 4 Natera, Inc. For: Jan 16 Filed by: Chapman Steven Leonard
-
Form 4 Natera, Inc. For: Jan 16 Filed by: Brophy Michael Burkes
-
Form 4 Natera, Inc. For: Jan 16 Filed by: Fesko John
-
Form 4 Natera, Inc. For: Jan 16 Filed by: Moshkevich Solomon
-
Form 4 ReposiTrak, Inc. For: Jan 21 Filed by: FIELDS RANDALL K
-
Form SCHEDULE 13G Priority Technology Hold Filed by: Divisadero Street Capital Management, LP
-
Form 4 Enovix Corp For: Jan 18 Filed by: Talluri Rajendra K
-
Form 4 MDB Capital Holdings, For: Jan 16 Filed by: DIGIANDOMENICO ANTHONY
-
Form 4 PINTEREST, INC. For: Jan 20 Filed by: Ready William J
-
Form SCHEDULE 13G Dave Inc./DE Filed by: Divisadero Street Capital Management, LP
-
Form 3 Blaize Holdings, Inc. For: Jan 13 Filed by: Ava Investors SA
-
Form 4 Owlet, Inc. For: Jan 16 Filed by: Crawford Amanda
-
Form 144 Blueprint Medicines Corp Filed by: Albers Jeffrey W.
-
Form 4 Owlet, Inc. For: Jan 07 Filed by: Harris Jonathan
-
Form SCHEDULE 13G Blaize Holdings, Inc. Filed by: Ava Investors SA
-
Form 4 MeiraGTx Holdings plc For: Jan 21 Filed by: Giroux Richard
-
Form 4 TSS, Inc. For: Jan 16 Filed by: MARROTT KARL TODD
-
Form 4 TSS, Inc. For: Jan 16 Filed by: CHISM DANIEL M
-
Form 4 TSS, Inc. For: Jan 16 Filed by: Dewan Darryll E
-
Form 144 Aura Biosciences, Inc. Filed by: de los Pinos Elisabet
-
Form 144 Aura Biosciences, Inc. Filed by: Elazzouzi Amy
-
Form 4 Aura Biosciences, Inc. For: Jan 21 Filed by: de los Pinos Elisabet
-
Form 4 Aura Biosciences, Inc. For: Jan 21 Filed by: Elazzouzi Amy
-
Form SCHEDULE 13D/A Desktop Metal, Inc. Filed by: EBRAHIMI FARHAD FRED
-
Form SCHEDULE 13D/A NextDecade Corp. Filed by: VALINOR MANAGEMENT, L.P.
-
Form 144 MeiraGTx Holdings plc Filed by: Giroux Richard
-
Form SCHEDULE 13D/A ENVIRI Corp Filed by: Neuberger Berman Group LLC
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Ralston Dianne B.
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Kasibhatla Vijay
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Al Mogharbel Khaled
-
Form 4 Harmony Biosciences Hold For: Jan 16 Filed by: Dierks Jeffrey
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Prechner Ugo
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Guild Howard
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Biguet Stephane
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Rennick Gavin
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Rando Bejar Carmen
-
Form SCHEDULE 13D/A Verona Pharma plc Filed by: Growth Equity Opportunities Fund IV, LLC
-
Form 4 TILLY'S, INC. For: Jan 16 Filed by: Pleasant Lake Partners LLC
-
Form 4 TILE SHOP HOLDINGS, INC. For: Jan 16 Filed by: Pleasant Lake Partners LLC
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Pafitis Demosthenis
-
Form 4 FlexShopper, Inc. For: Jan 16 Filed by: Dvorkin Howard
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Jaggi Rakesh
-
Form 144 BlackRock, Inc. Filed by: Kushel J. Richard
-
Form 4 SCHLUMBERGER LIMITED/NV For: Jan 17 Filed by: Le Peuch Olivier
-
Form 144 Pampa Energy Inc. Filed by: Mindlin Marcos Marcelo
